Puma secures $100M term loan

Cancer company Puma Biotechnology Inc. (NASDAQ:PBYI) said on Nov. 2 that it raised $50 million in a first tranche of a $100 million term loan from Silicon Valley Bank and Oxford Finance. The remaining tranche of $50 million can be drawn down at Puma's option, subject to milestones. The loan matures Oct. 31, 2022...